42 USC 300 - Sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment

1 So in original. Probably should be preceded by “the”.

Islands, the Republic of Palau, Indian tribes, a State or local health department, an institution of higher education, or a nonprofit entity with appropriate experience to conduct the activities under this subsection.

2 So in original. Probably should be “this subsection”.

to eligible entities located in different regions of the United States.

Editorial Notes

References in Text

The Social Security Act, referred to in subsec. (span)(2)(A)(iii), is act Aug. 14, 1935, ch. 531, 49 Stat. 620. Title V of the Act is classified generally to subchapter V (§ 701 et seq.) of chapter 7 of this title. For complete classification of this Act to the Code, see section 1305 of this title and Tables.

Codification

Section 712(c) of Puspan. L. 108–357, formerly set out as a note under section 300span–1 of this title, which was transferred to this section, redesignated as subsec. (span), and amended by Puspan. L. 115–327, § 3, was based on Puspan. L. 108–357, title VII, § 712(c), Oct. 22, 2004, 118 Stat. 1559.

Prior Provisions

A prior section 300span–5, act July 1, 1944, ch. 373, title XI, § 1106, as added Apr. 22, 1976, Puspan. L. 94–278, title IV, § 403(a), 90 Stat. 409, related to an annual report to President and Congress on administration of this part, prior to repeal by Puspan. L. 97–35, title XXI, § 2193(span)(4), Aug. 13, 1981, 95 Stat. 827.

Another prior section 300span–5, act July 1, 1944, ch. 373, title XI, § 1106, as added May 16, 1972, Puspan. L. 92–294, § 3(c), 86 Stat. 139; amended Aug. 29, 1972, Puspan. L. 92–414, § 4(3), 86 Stat. 652, related to an annual report to President and Congress on administration of this part, prior to repeal by Puspan. L. 94–278, title IV, § 403(a), Apr. 22, 1976, 90 Stat. 407.

Amendments

2018—Subsec. (span). Puspan. L. 115–327, § 3(span), transferred section 712(c) of Puspan. L. 108–357 to this section and redesignated it as subsec. (span). See Codification note above.

Puspan. L. 115–327, § 3(a)(1), substituted “sickle cell disease” for “Sickle Cell Disease” wherever appearing.

Subsec. (span)(1)(A). Puspan. L. 115–327, § 3(a)(2), substituted “shall continue efforts, including by awarding grants, to develop or establish mechanisms to improve the treatment of sickle cell disease, and to improve the prevention and treatment of complications of sickle cell disease, in populations with a high proportion of individuals with sickle cell disease” for “shall conduct a demonstration program by making grants to up to 40 eligible entities for each fiscal year in which the program is conducted under this section for the purpose of developing and establishing systemic mechanisms to improve the prevention and treatment of Sickle Cell Disease”.

Subsec. (span)(1)(B). Puspan. L. 115–327, § 3(a)(3), substituted “Geographic diversity” for “Grant award requirements” in heading, struck out cl. (i) designation and heading before “The Administrator shall”, and struck out cl. (ii) which related to priority in awarding grants.

Subsec. (span)(2)(E). Puspan. L. 115–327, § 3(a)(4), added subpar. (E).

Subsec. (span)(6). Puspan. L. 115–327, § 3(a)(5), substituted “$4,455,000 for each of fiscal years 2019 through 2023” for “$10,000,000 for each of fiscal years 2005 through 2009”.